MariMed Inc. (MRMD)
| Market Cap | 31.11M -42.4% |
| Revenue (ttm) | 163.82M +4.5% |
| Net Income | -14.95M |
| EPS | -0.04 |
| Shares Out | 403.04M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 451,415 |
| Open | 0.0750 |
| Previous Close | 0.0790 |
| Day's Range | 0.0714 - 0.0770 |
| 52-Week Range | 0.0610 - 0.1780 |
| Beta | 1.36 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Nov 11, 2026 |
About MariMed
MariMed Inc. engages in cultivation, production, and selling of branded cannabis products in the United States. The company sells cannabis flower, vapes, and concentrates under the Nature’s Heritage brand; and cannabis fruit chews that delivers better sleep, pain relief, stress relief, and others under Betty’s Eddies brand. It offers soft and chewy baked goods and a hot chocolate mix under Bubby’s Baked brand; cannabis-infused hydrating drink mix for discrete and on-the-go consumption under Vibations brand; and flower, vapes, and edibles under ... [Read more]
Full Company ProfileFinancial Performance
In 2025, MariMed's revenue was $159.83 million, an increase of 1.34% compared to the previous year's $157.71 million. Losses were -$14.48 million, 16.2% more than in 2024.
Financial StatementsNews
MariMed Proxy statement: Proxy filing
MariMed filed a proxy statement on September 11, 2026, providing details for shareholder voting and corporate governance matters.
MariMed Earnings Call Transcript: Q2 2026
Record quarterly revenue and sequential growth in both wholesale and retail segments, with adjusted EBITDA up 10% from the prior quarter. Margin pressure from price competition is expected to be transitional, with new market entries and product innovation supporting future expansion.
MariMed Earnings release: Q2 2026
MariMed released its Q2 2026 earnings on August 13, 2026, summarizing the period's financial results.
MariMed Slides: Q2 2026
MariMed has posted slides in relation to its Q2 2026 quarterly earnings report, which was published on August 13, 2026.
MariMed Quarterly report: Q2 2026
MariMed has published its Q2 2026 quarterly earnings report on August 13, 2026.
MariMed Reports Second Quarter 2026 Earnings
NORWOOD, Mass., Aug. 12, 2026 (GLOBE NEWSWIRE) -- MariMed Inc. (“MariMed” or the “Company”) (CSE: MRMD) (OTCQB: MRMD), a leading multi-state cannabis operator focused on improving lives every day, tod...
MariMed Embraces Pumpkin Season By Unveiling New Products That Bring Seasonal Autumn Flavors to Cannabis Consumers
NORWOOD, Mass., Aug. 06, 2026 (GLOBE NEWSWIRE) -- Leading multi-state cannabis operator, MariMed Inc. (“MariMed”) (CSE: MRMD) (OTCQB:MRMD) is gearing up for a cozy fall with a line of limited-edition ...
MariMed Announces Second Quarter 2026 Earnings Date
NORWOOD, Mass., July 15, 2026 (GLOBE NEWSWIRE) -- MariMed Inc. (“MariMed” or the “Company”) (CSE: MRMD) (OTCQB: MRMD), a leading cannabis consumer packaged goods company and retailer, announced today ...
MariMed's Betty's Eddies™ Expands Core Lineup with New Multi-Vitamin Inspired Betty's Bite-A-Mins
NORWOOD, Mass., July 14, 2026 (GLOBE NEWSWIRE) -- Betty's Eddies ™, the all-natural cannabis fruit chews handcrafted for specific health and wellness effects, is expanding its core lineup with the int...
MariMed's Nature's Heritage Launches “The Nose Knows” Immersive, Science-Backed Consumer Education Campaign
NORWOOD, Mass., July 07, 2026 (GLOBE NEWSWIRE) -- MariMed's (“MariMed”) (CSE: MRMD) (OTCQB: MRMD) award-winning flower, vape and concentrate brand, Nature's Heritage™ , today announced the launch of ‘...
MariMed Submits DEA Registration Applications For State-Licensed Medical Cannabis Businesses
NORWOOD, Mass., June 25, 2026 (GLOBE NEWSWIRE) -- MariMed Inc. (“MariMed” or the “Company”) (CSE: MRMD) (OTCQB: MRMD), a leading multi-state cannabis operator, today announced the Company has submitte...
MariMed Presents Fourth Annual Bob Fireman Entrepreneur of the Year Award to Weldon Angelos
NORWOOD, Mass., June 16, 2026 (GLOBE NEWSWIRE) -- Leading multi-state cannabis operator MariMed Inc. (“MariMed”) (CSE: MRMD) (OTCQB: MRMD) proudly presented the Fourth Annual Bob Fireman Entrepreneur ...
MariMed Transcript: AGM 2026
The meeting confirmed a quorum, re-elected all board nominees, and approved the independent auditor for 2026. Management addressed regulatory changes and expressed optimism for future stock performance, emphasizing ongoing strategic focus and shareholder engagement.
MariMed Earnings Call Transcript: Q1 2026
Q1 2026 saw 4% revenue growth year-over-year, stable gross margins, and improved profitability, driven by strong wholesale and retail performance in core markets. Expansion is planned in Massachusetts and Ohio, with immediate tax benefits expected from medical cannabis rescheduling.
MariMed Earnings release: Q1 2026
MariMed released its Q1 2026 earnings on May 14, 2026, summarizing the period's financial results.
MariMed Slides: Q1 2026
MariMed has posted slides in relation to its Q1 2026 quarterly earnings report, which was published on May 14, 2026.
MariMed Quarterly report: Q1 2026
MariMed has published its Q1 2026 quarterly earnings report on May 14, 2026.
MariMed Reports First Quarter 2026 Earnings
NORWOOD, Mass., May 13, 2026 (GLOBE NEWSWIRE) -- MariMed Inc. (“MariMed” or the “Company”) (CSE: MRMD) (OTCQB: MRMD), a leading multi-state cannabis operator focused on improving lives every day, toda...
MariMed Proxy statement: Proxy filing
MariMed filed a proxy statement on April 23, 2026, providing details for shareholder voting and corporate governance matters.
MariMed Announces First Quarter 2026 Earnings Date
NORWOOD, Mass., April 15, 2026 (GLOBE NEWSWIRE) -- MariMed Inc. (“MariMed” or the “Company”) (CSE: MRMD) (OTCQB: MRMD), a leading cannabis consumer packaged goods company and retailer, announced today...
MariMed Earnings Call Transcript: Q4 2025
Revenue grew 7% to $160M in 2025, with strong wholesale gains and expanded brand reach via licensing. Margin discipline, positive cash flow, and a strengthened balance sheet position the company for further growth, despite ongoing price compression in mature markets.
MariMed Annual report: Q4 2025
MariMed has published its Q4 2025 annual report on March 12, 2026.
MariMed Earnings release: Q4 2025
MariMed released its Q4 2025 earnings on March 12, 2026, summarizing the period's financial results.
MariMed Slides: Q4 2025
MariMed has posted slides in relation to its Q4 2025 quarterly earnings report, which was published on March 12, 2026.
MariMed Reports Fourth Quarter and Full Year 2025 Earnings
NORWOOD, Mass., March 11, 2026 (GLOBE NEWSWIRE) -- MariMed Inc. (“MariMed” or the “Company”) (CSE: MRMD) (OTCQX: MRMD), a leading multi-state cannabis operator focused on improving lives every day, to...